Differential recognation by CD28 of its cognate counter receptors CD80 (B7.1) and B70 (B7.2): Analysis by site directed mutagenesis

Molecular Immunology

Volumn 33, Issue 3, 1996, Pages 321-334

  Truneh, Alemseged ^a   Reddy, Manjula ^a   Ryan, Patricia ^a   Lyn, Sally D ^a   Eichman, Christopher ^a   Couez, Dominique ^a   Hurle, Mark R ^a   Sekaly, Raffick P ^b   Olive, Daniel ^c   Sweet, Raymond ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

^b CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^c INSERM   (France)

Author keywords

B7.1; B7.2; B70; CD28; CD80; CD86; CTLA 4; Epitope mapping; Ig fold; IgSf; Receptor recognition; Site directed mutagenesis

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD86 ANTIGEN; HYBRID PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; EPITOPE MAPPING; FIBROBLAST; HYBRIDOMA; IMMUNOREGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD80; ANTIGENS, CD86; ANTIGENS, DIFFERENTIATION; BASE SEQUENCE; BINDING SITES, ANTIBODY; CELL ADHESION; EPITOPE MAPPING; FLOW CYTOMETRY; GENETIC VECTORS; HUMANS; IMMUNOCONJUGATES; IMMUNOGLOBULIN VARIABLE REGION; L CELLS (CELL LINE); MEMBRANE GLYCOPROTEINS; MICE; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PROTEIN FOLDING; SEQUENCE ALIGNMENT;

ANIMALIA;

EID: 0029883005     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/0161-5890(95)00077-1     Document Type: Article

References (38)

1. Aiyar N., Baker E., Wu H. L., Nambi P., Edwards R. M., Trill J. J., Ellis C. and Bergsma, D. J. (1994) Human AT1 receptor is a single copy gene: characterization in a stable cell line. Molec. cell. Biochem. 131(1), 75-86.
2. Amzel L. M. and Poljak R. J. (1979) Three-dimensional structure of immunoglobulins. Review. A. Rev. Biochem. 48, 961-997.
3. Aruffo A. and Seed B. (1987) Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system. Proc. natn. Acad. Sci. U.S.A. 84(23), 8573-8577.
4. Azuma M., Cayabyab M., Buck D., Phillips J. H. and Lanier L. L. (1992) CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes. J. exp. Med. 17(2), 353-360.
5. Azuma M., Ito D., Yagita H., Okumura K., Phillips J. H., Lanier L. L. and Somoza C. (1993) B70 antigen is a second ligand for CTLA-4 and CD28. Nature 366(6450), 76-79.
6. Boussiotis V. A., Freeman G. J., Gribben J. G., Daley J., Gray G. and Nadler L. M. (1993) Activated human B lymphocytes express three CTLA-4 counterreceptors that costimulate T-cell activation. Proc. natn. Acad. Sci. U.S.A. 90(23), 11,059-11,063.
7. Brunet J. F., Denizot F., Luciani M. F., Roux D. M., Suzan M., Mattei M. G. and Golstein P. (1987) A new member of the immunoglobulin superfamily-CTLA-4. Nature 328(6127), 267-270.
8. Clark G. J. and Dallman M. J. (1992) Identification of a cDNA encoding the rat CD28 homologue. Immunogenetics 35(1), 54-57.
9. Couez D., Pages F., Ragueneau M., Nunes J., Klasen S., Mawas C., Truneh A. and Olive D. (1994) Functional expression of human CD28 in murine T cell hybridomas. Molec. Immun. 31(1), 47-57.
10. Dariavach P., Mattei M. G., Golstein P. and Lefranc M. P. (1988) Human Ig superfamily CTLA-4 gene: chromosomal localization and identity of protein sequence between murine and human CTLA-4 cytoplasmic domains. Eur. J. Immun. 18(12), 1901-1905.
11. Fargeas C. A., Truneh A., Reddy M., Hurle M., Sweet R. and Sekaly R. P. (1995) Identification of residues in the V domain of CD80 (B7-1) implicated in functional interactions with CD28 and CTLA4. J. exp. Med. 182, 667-675.
12. Freeman G. J., Borriello F., Hodes R. J., Reiser H., Gribben J. G., Ng J. W., Kim J., Goldberg J. M., Hathcock K., Laszlo G. et al. (1993a) Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production. J. exp. Med. 178(6), 2185-2192.
13. Freeman G. J., Gray G. S., Gimmi C. D., Lombard D. B., Zhou L. J., White M., Fingeroth J. D., Gribben J. G. and Nadler L. M. (1991) Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7. J. exp. Med. 174(3), 625-631.
14. Freeman G. J., Gribben J. G., Boussiotis V. A., Ng J. W., Restivo V. A. J., Lombard L. A., Gray G. S. and Nadler L. M. (1993b) Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation [see comments]. Science 262(5135), 909-911.
15. Gross J. A., St John T. and Allison J. P. (1990) The murine homologue of the T lymphocyte antigen CD28. Molecular cloning and cell surface expression. J. Immun. 144(8), 3201-3210.
16. Guinan E. C., Gribben J. G., Boussiotis V. A., Freeman G. J. and Nadler L. M. (1994) Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity. Blood 84(10), 3261-3282.
17. Gunning P., Leavitt J., Muscat G., Ng S. Y. and Kedes L. (1987) A human beta-actin expression vector system directs high-level accumulation of antisense transcripts. Proc. natn. Acad. Sci. U.S.A. 84(14), 4831-4835.
18. Harper K., Balzano C., Rouvier E., Mattei M. G., Luciani M. F. and Golstein P. (1991) CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location. J. Immun. 147(3), 1037-1044.
19. Hathcock K. S., Laszlo G., Dickler H. B., Bradshaw J., Linsley P. and Hodes R. J. (1993) Identification of an alternative CTLA-4 ligand costimulatory for T cell activation [see comments]. Science 262(5135), 905-907.
20. Kabat E. A., Wu T. T., Perry H. M., Gottesman K. S. and Foeller, C. (1991) Sequences of Proteins of Immunological Interest. U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health.
21. Larsen C. P., Ritchie S. C., Hendrix R., Linsley P. S., Hathcock K. S., Hodes R. J., Lowry R. P. and Pearson T. C. (1994) Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells. J. Immun. 152(11), 5208-5219.
22. Leahy D. J., Axel R. and Hendrickson W. A. (1992) Crystal structure of a soluble form of the human T cell coreceptor CD8 at 2.6 A resolution. Cell 68(6), 1145-1162.
23. Linsley P. S., Brady W., Urnes M., Grosmaire L. S., Damle N. K. and Ledbetter J. A. (1991) CTLA-4 is a second receptor for the B cell activation antigen B7. J. exp. Med. 174(3), 561-569.
24. Linsley P. S., Clark E. A. and Ledbetter J. A. (1990) T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. Proc. natn. Acad. Sci. U.S.A. 87(13), 5031-5035.
25. Nunes J., Klasen S., Ragueneau M., Pavon C., Couez D., Mawas C., Bagnasco M. and Olive D. (1993) CD28 mAbs with distinct binding properties differ in their ability to induce T cell activation: analysis of early and late activation events. Int. Immun. 5(3), 311-315.
26. Padlan E. A. (1994) Anatomy of the antibody molecule. [Review]. Molec. Immun. 31(3), 169-217.
27. Pages F., Ragueneau M., Rottapel R., Truneh A., Nunes J., Imbert J. and Olive D. (1994) Binding of phosphatidylinositol-3-OH kinase to CD28 is required for T-cell signalling. Nature 369(6478), 327-329.
28. Pastori R. L., Milde K. F. and Alejandro R. (1994) Molecular cloning of the dog homologue of the lymphocyte antigen CD28. Immunogenetics 39(5), 373.
29. Peach R. J., Bajorath J., Brady W., Leytze G., Greene J., Naemura J. and Linsley P. S. (1994) Complementarity determining region 1 (CDR1)-and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1. J. exp. Med. 180, 2049-2058.
30. Powers G. D., Faherty D. A., Connaughton S. E., Biondi D. A., Godfrey, D. I., Gault, A., Chen C. Y. and Nabavi, N. (1994) Expression and functional analysis of murine B7 delineated by a novel monoclonal antibody. Cell. Immun. 153(2), 298-311.
31. Radcliff G., Waite R., LeFevre J., Poulik M. D. and Callewaert D. M. (1991) Quantification of effector/target conjugation involving natural killer (NK) or lymphokine activated killer (LAK) cells by two-color flow cytometry. J. immun. Meth. 139(2), 281-292.
32. Richardson J. S. and Richardson D. C. (1989) Principles and patterns of protein conformation. Prediction of Protein Structure and the Principles of Protein Conformation (Edited by G. D. Fasman), pp. 1-98. Plenum Press, New York.
33. Stein P. H., Fraser J. D. and Weiss A. (1994) The cytoplasmic domain of CD28 is both necessary and sufficient for costimulation of interleukin-2 secretion and association with phosphatidylinositol 3'-kinase. Molec. cell. Biol. 14(5), 3392-3402.
34. Takebe Y., Seiki M., Fujisawa J., Hoy P., Yokota K., Arai K., Yoshida M. and Arai N. (1988) SR alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat. Molec. cell. Biol. 8(1), 466-472.
35. Truneh A., Reddy M., Couez D., Kokolis C., Eichman C., Fargeas C., Sekaly R., Sweet R. and Olive D. (1995) Analysis of CD28-and B7-mediated T cell adhesion and IL-2 production using a panel of mAbs and CTLA4-Ig and B7-Ig. Leukocyte Typing V, Vol. 1 (Edited by S. F. Schlossmann et al.), pp. 370-372. Oxford University Press, Oxford.
36. Williams A. F. and Barclay A. N. (1988) The immunoglobulin superfamily-domains for cell surface recognition. [Review]. A. Rev. Immun. 6, 381-405.
37. Yokochi T., Holly R. D. and Clark E. A. (1982) B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts. B lymphoblastoid cell lines, and Burkitt's lymphomas. J. Immun. 128(2), 823-827.
38. Young J. R., Davison T. F., Tregaskes C. A., Rennie M. C. and Vainio O. (1994) Monomeric homologue of mammalian CD28 is expressed on chicken T cells. J. Immun. 152(8), 3848-3851.